Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov;17(11):e015982.
doi: 10.1161/CIRCIMAGING.124.015982. Epub 2024 Nov 19.

Current and Emerging Approaches to Imaging Large Vessel Vasculitis

Affiliations
Review

Current and Emerging Approaches to Imaging Large Vessel Vasculitis

Ahmed Tawakol et al. Circ Cardiovasc Imaging. 2024 Nov.

Abstract

Large vessel vasculitides (LVV) comprise a group of inflammatory disorders that involve the large arteries, such as the aorta and its primary branches. The cause of LVV is often rheumatologic and includes giant cell arteritis and Takayasu arteritis. Giant cell arteritis is the most common form of LVV affecting people >50 years of age with a slight female predominance. Takayasu arteritis is more frequently seen in younger populations and is significantly more common in women. Prompt identification of LVV is crucial as it can lead to debilitating complications if left untreated, including blindness in the case of giant cell arteritis and large artery stenosis and aneurysms in the case of all forms of LVV. Noninvasive imaging methods have greatly changed the approach to managing LVV. Today, imaging (with ultrasound, magnetic resonance imaging, computed tomography, and positron emission tomography) is routinely used in the diagnosis of LVV. In patients with giant cell arteritis, imaging often spares the use of invasive procedures such as temporal artery biopsy. In addition, vascular imaging is also crucial for longitudinal surveillance of arterial damage. Finally, imaging is currently being studied for its role in assessing treatment response and ongoing disease activity and its potential value in determining the presence of vascular wall remodeling (eg, scarring). This review explores the current uses of noninvasive vascular imaging in LVV.

Keywords: Computed tomography; Takayasu arteritis; aorta; giant cell arteritis; magnetic resonance imaging; positron-emission tomography.

PubMed Disclaimer

Conflict of interest statement

Dr Tawakol receives research support (to his institution) from Lung Biotechnologies and consulting fees from Cunningham Bounds LLC for unrelated work and is supported by National Institutes of Health (NIH) R01HL152957, R33HL141047, R01HL1495, P01HL131478, R01AR077187, and R01HL16433, and the International Atomic Energy Agency (IAEA) for unrelated work. Dr Weber receives consulting fees from Novo Nordisk, Kiniksa, and Horizon Therapeutics (now Amgen) for unrelated work, and is supported by NIH/NHLBI K23HL159276 and American Heart Association 21CDA851511. Dr Osborne receives consulting fees from WCG Clinical for unrelated work, and is supported by the NIH K23HL151909 and the American Heart Association 23SCISA1143491. Dr Bucerius receives institutional funding from the IAEA in the context of the PIAF (Prognostic Value of Arterial 18F-FDG PET Imaging in Patients with History of Myocardial Infarction) trial (core laboratory). Dr Unizony reports Research support from Genentech, NIH 1UM1AI144295-01 for unrelated work, and consulting fees from Novartis, Sanofi, and Harvard Pilgrim Health Care. The other authors report no conflicts.

References

    1. Unizony S. Giant cell arteritis & polymyalgia rheumatica. In: Hill M, ed. Current Diagnosis and Treatment: Rheumatology. McGraw Hill; 2021:279–292.
    1. Unizony S Takayasu arteritis. In: Stone JH, ed. Current Diagnosis & Treatment: Rheumatology, 4e. McGraw Hill; 2021
    1. Dejaco C, Ramiro S, Bond M, Bosch P, Ponte C, Mackie SL, Bley TA, Blockmans D, Brolin S, Bolek EC, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update. Ann Rheum Dis. 2024;83:741–751. doi: 10.1136/ard-2023-224543 - DOI - PubMed
    1. Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A, Craven A, Khalid S, Hutchings A, Watts RA, et al.; DCVAS Study Group. 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis. 2022;81:1647–1653. doi: 10.1136/ard-2022-223480 - DOI - PubMed
    1. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129–1134. doi: 10.1002/art.1780330811 - DOI - PubMed

LinkOut - more resources